Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

Lipocalin 2 (LCN2) is a small secreted protein and its elevated expression has been observed in pancreatic as well as other cancer types. LCN2 has been reported to promote resistance to drug-induced apoptosis, enhance invasion through its physical association with matrix metalloproteinase-9, and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Lisa, Radulovich, Nikolina, Zhu, Chang-Qi, Organ, Shawna, Bandarchi, Bizhan, Pintilie, Melania, To, Christine, Panchal, Devang, Tsao, Ming Sound
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464270/
https://www.ncbi.nlm.nih.gov/pubmed/23056397
http://dx.doi.org/10.1371/journal.pone.0046677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464270/
https://www.ncbi.nlm.nih.gov/pubmed/23056397
http://dx.doi.org/10.1371/journal.pone.0046677

Ejemplares similares